Multiple stimulus-response berberine plus baicalin micelles with particle size-charge-release triple variable properties for breast cancer therapy

References

• De Cicco P, Catani MV, Gasperi V, et al. Nutrition and breast cancer: a literature review on prevention, treatment and recurrence. Nutrients. 2019;11(7):1514.
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women’s health initiative randomized clinical trials. JAMA. 2020;324(4):369–380.
   PubMed Web of Science ®Google Scholar
• Guha A, Fradley MG, Dent SF, et al. Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis. Eur Heart J. 2022;43(4):300–312.
   PubMed Web of Science ®Google Scholar
• Dolatkhah M, Hashemzadeh N, Barar J, et al. Graphene-based multifunctional nanosystems for simultaneous detection and treatment of breast cancer. Colloids Surf B Biointerfaces. 2020;193:111104.
   PubMed Web of Science ®Google Scholar
• Łukasiewicz S, Czeczelewski M, Forma A, et al. Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers. 2021;13(17):4287.
   PubMed Web of Science ®Google Scholar
• Medeiros B, Allan AL. Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives. Int J Mol Sci. 2019;20(9):2272.
   PubMed Web of Science ®Google Scholar
• Bai X, Ni J, Beretov J, et al. Cancer stem cell in breast cancer therapeutic resistance. Cancer Treat Rev. 2018;69:152–163.
   PubMed Web of Science ®Google Scholar
• Su X, Hou NN, Yang LJ, et al. The first competing risk survival nomogram in patients with papillary renal cell carcinoma. Sci Rep. 2021;11(1):11835.
   PubMed Web of Science ®Google Scholar
• Garcia EA, Simoes K, Wakamatsu A, et al. Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions. Endocr Pathol. 2010;21(2):101–107.
   PubMed Web of Science ®Google Scholar
• Sobierajska K, Ciszewski WM, Sacewicz-Hofman I, et al. Endothelial cells in the tumor microenvironment. Adv Exp Med Biol. 2020;1234:71–86.
   PubMed Web of Science ®Google Scholar
• Bruand M, Barras D, Mina M, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021;36(3):109412.
   PubMed Web of Science ®Google Scholar
• , Lopez-Gonzalez JS, Garcia-Vazquez R, Hernandez de la Cruz ON, et al. Regulation networks driving vasculogenic mimicry in solid tumors. Front Oncol. 2019;9:1419.
   PubMed Web of Science ®Google Scholar
• Habtemariam S. Berberine pharmacology and the gut microbiota: a hidden therapeutic link. Pharmacol Res. 2020;155:104722.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang S, Wu L, et al. Berberine inhibited metastasis through miR-145/MMP16 axis in vitro. J Ovarian Res. 2021;14(1):4.
   PubMed Web of Science ®Google Scholar
• Liu L, Sun L, Zheng J, et al. Berberine modulates keratin 17 to inhibit cervical cancer cell viability and metastasis. J Recept Signal Transduct Res. 2021;41(6):521–531.
   PubMed Web of Science ®Google Scholar
• Huang T, Liu Y, Zhang C. Pharmacokinetics and bioavailability enhancement of baicalin: a review. Eur J Drug Metab Pharmacokinet. 2019;44(2):159–168.
   PubMed Web of Science ®Google Scholar
• Singh S, Meena A, Luqman S. Baicalin mediated regulation of key signaling pathways in cancer. Pharmacol Res. 2021;164:105387.
   PubMed Web of Science ®Google Scholar
• Zhang CH, Yu RY, Liu YH, et al. Interaction of baicalin with berberine for glucose uptake in 3T3-L1 adipocytes and HepG2 hepatocytes. J Ethnopharmacol. 2014;151(2):864–872.
   PubMed Web of Science ®Google Scholar
• Wang N, Feng Y, Cheung F, et al. A Chinese medicine formula Gegen Qinlian decoction suppresses expansion of human renal carcinoma with inhibition of matrix metalloproteinase-2. Integr Cancer Ther. 2015;14(1):75–85.
   PubMed Web of Science ®Google Scholar
• Martinez JO, Evangelopoulos M, Bhavane R, et al. Multistage nanovectors enhance the delivery of free and encapsulated drugs. CDT. 2015;16(14):1582–1590.
   Google Scholar
• Zhu Y, Liu R, Huang H, et al. Vinblastine-loaded nanoparticles with enhanced tumor-targeting efficiency and decreasing toxicity: developed by one-step molecular imprinting process. Mol Pharm. 2019;16(6):2675–2689.
   PubMedGoogle Scholar
• Sakurai Y, Harashima H. Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opin Drug Deliv. 2019;16(9):915–936.
   PubMed Web of Science ®Google Scholar
• Hua S, He J, Zhang F, et al. Multistage-responsive clustered nanosystem to improve tumor accumulation and penetration for photothermal/enhanced radiation synergistic therapy. Biomaterials. 2021;268:120590.
   PubMed Web of Science ®Google Scholar
• Rashidzadeh H, Rezaei SJT, Zamani S, et al. pH-sensitive curcumin conjugated micelles for tumor triggered drug delivery. J Biomater Sci Polym Ed. 2021;32(3):320–336.
   PubMed Web of Science ®Google Scholar
• Ping L, Zhang K, Ou X, et al. A novel pyroptosis-associated long non-coding RNA signature predicts prognosis and tumor immune microenvironment of patients with breast cancer. Front Cell Dev Biol. 2021;9:727183.
   PubMed Web of Science ®Google Scholar
• Acharyya S, Oskarsson T, Vanharanta S, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150(1):165–178.
   PubMed Web of Science ®Google Scholar
• Rayamajhi S, Marchitto J, Nguyen TDT, et al. pH-responsive cationic liposome for endosomal escape mediated drug delivery. Colloids Surf B Biointerfaces. 2020;188:110804.
   PubMed Web of Science ®Google Scholar
• Zhang ZT, Huang-Fu MY, Xu WH, et al. Stimulus-responsive nanoscale delivery systems triggered by the enzymes in the tumor microenvironment. Eur J Pharm Biopharm. 2019;137:122–130.
   PubMed Web of Science ®Google Scholar
• Sun H, Feng M, Chen S, et al. Near-infrared photothermal liposomal nanoantagonists for amplified cancer photodynamic therapy. J Mater Chem B. 2020;8(32):7149–7159.
   PubMed Web of Science ®Google Scholar
• Wei L, Wang C, Chen X, et al. Dual-responsive, methotrexate-loaded, ascorbic acid-derived micelles exert anti-tumor and anti-metastatic effects by inhibiting NF-kappaB signaling in an orthotopic mouse model of human choriocarcinoma. Theranostics. 2019;9(15):4354–4374.
   PubMed Web of Science ®Google Scholar
• Yu T, Zhuang W, Su X, et al. Dual-responsive micelles with aggregation-induced emission feature and two-photon aborsption for accurate drug delivery and bioimaging. Bioconjug Chem. 2019;30(7):2075–2087.
   PubMed Web of Science ®Google Scholar
• Shao J, Zaro J, Shen Y. Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate. IJN. 2020;15:9355–9371.
   Google Scholar
• Dheer D, Nicolas J, Shankar R. Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases. Adv Drug Deliv Rev. 2019;151–152:130–151.
   PubMed Web of Science ®Google Scholar
• Arrighetti N, Corbo C, Evangelopoulos M, et al. Exosome-like nanovectors for drug delivery in cancer. CMC. 2019;26(33):6132–6148.
   Google Scholar
• Chen L, Zhao T, Zhao M, et al. Size and charge dual-transformable mesoporous nanoassemblies for enhanced drug delivery and tumor penetration. Chem Sci. 2020;11(10):2819–2827.
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Xu C, et al. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy. Acta Biomater. 2021;134:546–558.
   PubMed Web of Science ®Google Scholar
• He Y, Lei L, Cao J, et al. A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting. Sci Adv. 2021;7(6):eaba0776.
   PubMed Web of Science ®Google Scholar
• Lu Z, Long Y, Cun X, et al. A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy. Nanoscale. 2018;10(21):9957–9970.
   PubMed Web of Science ®Google Scholar
• Tsuchiya K. Switching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor immunity. Int J Mol Sci. 2021;22(1):426.
   PubMed Web of Science ®Google Scholar
• Xu X, Lai Y, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2019;39(1):BSR20180992.
   PubMedGoogle Scholar
• Morales D, Lombart F, Truchot A, et al. 3D coculture models underline metastatic melanoma cell sensitivity to vemurafenib. Tissue Eng A. 2019;25(15–16):1116–1126.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee M, Song Y, et al. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2alpha/ATF4/CHOP axis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2021;40(1):127.
   PubMed Web of Science ®Google Scholar
• Dalir Abdolahinia E, Jafari B, Parvizpour S, et al. Role of cellulose family in fibril organization of collagen for forming 3D cancer spheroids: in vitro and in silico approach. Bioimpacts. 2020;11(2):111–117.
   PubMed Web of Science ®Google Scholar
• Sun B, Zhong FJ, Xu C, et al. Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated Yap activation. Cell Death Dis. 2021;12(9):849.
   PubMed Web of Science ®Google Scholar
• Ye Q, Wang X, Yuan M, et al. miR-219-5p targets TBXT and inhibits breast cancer cell EMT and cell migration and invasion. Biosci Rep. 2021;41(8):BSR20210318.
   PubMed Web of Science ®Google Scholar
• Luo Q, Wang J, Zhao W, et al. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol. 2020;13(1):19.
   PubMed Web of Science ®Google Scholar
• O'Melia MJ, Mulero-Russe A, Kim J, et al. Synthetic matrix scaffolds engineer the in vivo tumor immune microenvironment for immunotherapy screening. Adv Mater. 2022;34(10):e2108084.
   PubMed Web of Science ®Google Scholar
• Sun B, Zhang D, Zhao N, et al. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors. Oncotarget. 2017;8(18):30502–30510.
   PubMedGoogle Scholar
• Shan L. Near-infrared fluorescence 1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine iodide (DiR)-labeled macrophages for cell imaging. Bethesda (MD): Molecular Imaging and Contrast Agent Database (MICAD); 2004.
   Google Scholar
• Jia N, Li W, Liu D, et al. Tumor microenvironment stimuli-responsive nanoparticles for programmed anticancer drug delivery. Mol Pharm. 2020;17(5):1516–1526.
   PubMedGoogle Scholar
• Ma JB, Shen JM, Yue T, et al. Size-shrinkable and protein kinase calpha-recognizable nanoparticles for deep tumor penetration and cellular internalization. Eur J Pharm Sci. 2021;159:105693.
   PubMed Web of Science ®Google Scholar
• Ching MM, Reader J, Fulton AM. Eicosanoids in cancer: prostaglandin E2 receptor 4 in cancer therapeutics and immunotherapy. Front Pharmacol. 2020;11:819.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Luo C, Cho J, et al. Tryptanthrin exerts anti-breast cancer effects both in vitro and in vivo through modulating the inflammatory tumor microenvironment. Acta Pharm. 2021;71(2):245–266.
   PubMed Web of Science ®Google Scholar
• Eljuga D, Bulic K, Petrovecki M, et al. Reduced E-cadherin expression is a predictor of lower overall survival and metastatic disease in invasive ductal breast cancer. Onkologie. 2012;35(7-8):414–418.
   PubMedGoogle Scholar
• Loo WT, Jin L, Cheung MN, et al. Epigenetic change in E-cadherin and COX-2 to predict chronic periodontitis. J Transl Med. 2010;8:110.
   PubMed Web of Science ®Google Scholar